Randomized, Parallel Group, Controlled Trial to Compare Two Different "NMB + Reversal" Strategies in Adult Obese Patients Undergoing Laparoscopic Abdominal Surgery

Trial Profile

Randomized, Parallel Group, Controlled Trial to Compare Two Different "NMB + Reversal" Strategies in Adult Obese Patients Undergoing Laparoscopic Abdominal Surgery

Withdrawn prior to enrolment
Phase of Trial: Phase IV

Latest Information Update: 15 Jul 2015

At a glance

  • Drugs Sugammadex (Primary) ; Atropine; Cisatracurium besilate; Neostigmine; Rocuronium bromide; Suxamethonium chloride
  • Indications Neuromuscular blockade
  • Focus Therapeutic Use
  • Acronyms BENN
  • Sponsors Merck Sharp & Dohme
  • Most Recent Events

    • 10 Jul 2015 Planned End Date changed from 1 Jun 2016 to 1 Oct 2016 as reported by ClinicalTrials.gov.
    • 10 Jul 2015 Planned primary completion date changed from 1 Jun 2016 to 1 Oct 2016 as reported by ClinicalTrials.gov.
    • 10 Jul 2015 Status changed from not yet recruiting to withdrawn prior to enrolment as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top